161 related articles for article (PubMed ID: 35962990)
1. Synthesis, Biological Activity and Molecular Docking Studies of Heterocyclic Chalcones.
Kamra N; Rani S; Thakral S; Singh A; Sangwan PL; Singh SK; Thakral S; Singh V; Kumar D
Chem Biodivers; 2022 Sep; 19(9):e202200560. PubMed ID: 35962990
[TBL] [Abstract][Full Text] [Related]
2. Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: Synthesis, molecular docking and biological evaluation.
Desai V; Desai S; Gaonkar SN; Palyekar U; Joshi SD; Dixit SK
Bioorg Med Chem Lett; 2017 May; 27(10):2174-2180. PubMed ID: 28372908
[TBL] [Abstract][Full Text] [Related]
3. Morpholine Based Diazenyl Chalcones: Synthesis, Antimicrobial Screening and Cytotoxicity Study.
Kaur H; Desai SD; Singh J; Narasimhan B
Anticancer Agents Med Chem; 2018; 18(15):2193-2205. PubMed ID: 30173651
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
5. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial, Antiproliferative Effects and Docking Studies of Methoxy Group Enriched Coumarin-Chalcone Hybrids.
Badreddin Musatat A; Kılıçcıoğlu İ; Kurman Y; Dülger G; Alpay M; Yağcı R; Atahan A; Durmuş S
Chem Biodivers; 2023 Mar; 20(3):e202200973. PubMed ID: 36691991
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling based synthesis and evaluation of in vitro anticancer activity of indolyl chalcones.
Gaur R; Yadav DK; Kumar S; Darokar MP; Khan F; Bhakuni RS
Curr Top Med Chem; 2015; 15(11):1003-12. PubMed ID: 25860176
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer activity, molecular docking and molecular dynamics studies of some pyrazole-chalcone hybrids.
Al Otaibi AA; Alshammari SL; Dhahi Alsukaibi AK; Jamal A; Rajendrasozhan S; Alenezi KM; Hussain A; Khan I; Mushtaque M; Haque A
J Biomol Struct Dyn; 2024; 42(3):1381-1391. PubMed ID: 37071766
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Screening, in Silico Studies and QSAR of Chalcone-based 1,4-disubstituted 1,2,3-triazole Hybrids.
Yadav P; Lal K; Kumar A
Drug Res (Stuttg); 2021 Mar; 71(3):149-156. PubMed ID: 33285581
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
15. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Characterization and Biological Evaluation of Indole-Pyrazole Amalgamated α-Cyano Substituted Chalcones.
Bhale PS; Shringare SN; Khade AB; Chavan HV
Anticancer Agents Med Chem; 2021 Oct; 21(16):2216-2223. PubMed ID: 33563183
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, crystal structure and antimicrobial potential of some fluorinated chalcone-1,2,3-triazole conjugates.
Yadav P; Lal K; Kumar L; Kumar A; Kumar A; Paul AK; Kumar R
Eur J Med Chem; 2018 Jul; 155():263-274. PubMed ID: 29890388
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents.
Rostom SA; Badr MH; Abd El Razik HA; Ashour HM; Abdel Wahab AE
Arch Pharm (Weinheim); 2011 Sep; 344(9):572-87. PubMed ID: 21755528
[TBL] [Abstract][Full Text] [Related]
19. Chalcones bearing nitrogen-containing heterocyclics as multi-targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies.
Sıcak Y; Kekeçmuhammed H; Karaküçük-İyidoğan A; Taşkın-Tok T; Oruç-Emre EE; Öztürk M
J Mol Recognit; 2023 Jul; 36(7):e3020. PubMed ID: 37092742
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
